Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Endocrine 1

Conditions

Multiple Endocrine Neoplasia Type 1 1Depression 1

Interventions

Cyclophosphamide 910Carboplatin 788pembrolizumab 747Paclitaxel 744Bevacizumab 716Cisplatin 709Gemcitabine 621Docetaxel 584Rituximab 558Radiotherapy 548Dexamethasone 511Nivolumab 491Doxorubicin 445Fluorouracil 392Capecitabine 382Etoposide 358Pemetrexed 339Cytarabine 335Oxaliplatin 335Lenalidomide 328Prednisone 327Erlotinib Hydrochloride 323fludarabine phosphate 316Trastuzumab 305Leucovorin 299fludarabine 296Vincristine 288Bortezomib 284Filgrastim 284Cetuximab 277

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Mass Screening × Clear all
NCT01980771 2021-10-27

Barbershop Talk: HIV Prevention for African American Heterosexual Men

State University of New York - Downstate Medical Center

Phase NA Completed
860 enrolled 7 charts
Endocrine

Multiple Endocrine Neoplasia Type 1

NCT02273206 2020-03-12

PCM3

Clinical Directors Network

Phase NA Completed
802 enrolled 28 charts

Depression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡